Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries

Molecular Diversity

Volumn 2, Issue 3, 1997, Pages 135-146

  Ferry, Gilles ^a   Boutin, Jean A ^a   Atassi, Ghanem ^a   Fauchère, Jean Luc ^a   Tucker, Gordon C ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Metalloproteinase; MMP 2; MMP 9; Peptide libraries; Zymography

Indexed keywords

ANTINEOPLASTIC AGENT; COLLAGENASE; GELATINASE; GELATINASE A; GELATINASE B; HISTIDINE; METALLOPROTEINASE; OLIGOPEPTIDE; PEPTIDE LIBRARY; PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL CULTURE; CELL STRAIN 3T3; CHEMICAL STRUCTURE; CHEMISTRY; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG DESIGN; HUMAN; MOUSE; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; COLLAGENASES; CULTURE MEDIA, CONDITIONED; DRUG DESIGN; GELATINASES; HISTIDINE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PEPTIDE LIBRARY; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 33846808549     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01682201     Document Type: Article

References (58)

1. Brown, P.D., Matrix metalloproteinase inhibitors: A new class of anticancer agent, Curr. Opin. Invest. Drugs, 2 (1993) 617-626.
2. Woessner Jr., J.F., Matrix metalloproteinases and their inhibitors in connective tissue remodeling, FASEB 1, 5 (1991) 2145-2154.
3. Matrisian, L.M., The matrix degrading metalloproteinases, BioEssays, 14 (1992) 455-463.
4. Stetler-Stevenson, W.G., Liotta, L.A. and Kleiner, D.E., Role of matrix metalloproteinases in tumour invasion and metastasis, FASEB J., 7 (1993) 1434-1441.
5. Birkedal-Hansen, H., Proteolytic remodeling of extracellular matrix, Curr. Opin. Cell Biol., 7 (1995) 728-735.
6. Stetler-Stevenson, W.G., Type IV collagenases in tumor invasion and metastasis, Cancer Metastasis Rev., 9 (1990) 289-303.
7. Garbisa, S., Pozzati, R., Muschel, R.J., Saffiotti, U., Ballin, M., Goldfarb, R.H., Khoury, G. and Liotta, L.A., Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela, Cancer Res., 47 (1987) 1523-1528.
8. Bernhard, E.J., Gruber, S.B. and Muschel R.J., Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinasel collagenase) to the metastatic phenotype in transformed rat embryo cells, Proc. Natl. Acad. Sci. USA, 91 (1994) 4293-4297.
9. Auerbach, W. and Auerbach, R., Angiogenesis inhibition: A review, Pharmacol. Then, 63 (1994) 265-311.
10. Van den Hoof, A., Stromal involvement in malignant growth, Adv. Cancer Res., 50 (1988) 159-196.
11. Murphy, G. and Docherty, A.J.P., The matrix metalloproteinases and their inhibitors, Am. J. Respir. Cell Mol. Biol., 7 (1992) 120-125.
12. DeClerck, Y.A. and Imren, S., Protease inhibitors: Role and potential therapeutic use in human cancer, Eur. J. Cancer, 30A (1994) 2170-2180.
13. Schultz, R.M., Silberman, S., Persky, B., Bajkowsky, A.S. and Carmichael, D.F., Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and colonization by murine B16F10 melanoma cells, Cancer Res., 52 (1988) 5539-5545.
14. Takigawa, M., Nishida, Y., Suzuki, F., Kishi, J., Yamashita, K. and Hayakawa, T., Induction of angiogcnesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2), Biochem. Biophys. Res. Commun., 171 (1990) 1264-1271.
15. Albini, A., Melchiori, A., Santi, L., Liotta, L.A., Brown, P.D. and Stetler-Stevenson, W.G., Tumor cell invasion inhibited by TIMP-2, J. Natl. Cancer Inst., 83 (1991) 775-779.
16. Khokha, R., Suppression of the tumorigenic and metastasis abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1, J. Natl. Cancer Inst., 86 (1994) 299-303.
17. Koop, S., Khokha, R., Schmidt, E.E., MacDonald, I.C., Morris, V.L., Chambers, A.F. and Groom, A.C., Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumour growth, Cancer Res., 54 (1994) 4791-4797.
18. Montgomery, M.P., Mueller, B.M., Reisfeld, R.A., Taylor, S.M. and DeCIerck, Y.A., Effect of tissue inhibitor of matrix metalloprotease-2 expression on the growth and spontaneous metastasis of a human melanoma cell line, Cancer Res., 54 (1994) 5467-5473.
19. O'Shea, M., Willenbrock, F., Williamson, R.A., Cockett, M.I., Freedman, R.B., Reynolds, J.J., Docherty, A.J.P. and Murphy, G., Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: Importance of the N-terminal region between cysteine3 and cysteine 13, Biochemistry, 31 (1992) 10146-10152.
20. Bodden, M.K., Harber, G.J., Birkedal-Hansen, G., Windsor, L.J., Caterina, N.C.M., Engler, J.A. and Birkedal-Hansen, H., Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases), J. Biol. Chem., 269 (1994) 18943-18952.
21. Melchiori, A., Albini, A., Ray, J.M.and Stetler-Stevenson, W.G., Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment, Cancer Res., 52 (1992) 2353-2356.
22. Beeley, N.R., Ansel, P.R.J.and Docherty, A.J.P., Inhibitors of matrix metalloproteinases (MMP's), Curr. Opin. Ther. Patents, 4 (1994) 7-16.
23. Gray, R.D., Saneii, H.H.and Spatola, A.F., A fetal binding peptide inhibitors of vertebrate collagenase, Biochem. Biophys. Res. Commun., 101 (1981) 1251-1258.
24. Moore, W.M.and Spilburg, C.A., Purification of human collagenoses with a hydroxamic acid affinity column, Biochemistry, 25 (1986) 5189-5195.
25. Houghten, R.A., The broad utility of soluble peptide libraries for drug discovery, Gene, 137 (1993) 7-11.
26. Houghten, R.A., Clemencia, P., Blondelle, S.E., Appel, J. R., Dooley, C.T.and Cuervo, J.H., Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery, Nature, 354 (1991) 84-86.
27. Furka, A., Sebestyen, F, Asgedom, M.and Dibo, G., General method for rapid synthesis of multicomponent peptide mixtures, Int. J. Pept. Protein Res., 37 (1991) 487-493.
28. Lam, K.S., Salmon, S.E., Hersh, E.M., Hruby, V.J., Kazmierski, W.M.and Knapp, R.J., A new type of synthetic peptide library for identifying ligand-binding activity, Nature, 354 (1991) 82-84.
29. Pyke, C., Ralfkiaer, E., Triggvason, K.and Dano, K., Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer, Am. J. Pathol., 142 (1993) 359-365.
30. Wolf, C., Lefebvre, O., Rouyer, N., Chenard, M.P., Bellocq, J.P., Rio, M.C., Chambon, P.and Basset, P., Proteases d'origine stromale et progression tumorale, Med. Sci., 10 (1994) 507-515.
31. Heussen, C.and Dowdle, E.B., Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates, Anal. Biochem., 102 (1980) 196-202.
32. Montgomery, A.M.P., DeClerck, Y.A., Langley, K.E., Reisfeld, R. A.and Mueller, B.M., Melanoma-mediated dissolution of extracellular matrix. Contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res., 53 (1993) 693-700.
33. Bickett, D.M., Green, M.D., Berman, J., Dezube, M., Howe, A.S., Brown, P.J., Roth, J.T.and McGeehan, G.M., A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9), Anal. Biochem., 212 (1993) 58-64.
34. Zuckermann, R.N., Kerr, J.M., Siani, M.A., Banville, S.C.and Santi, D.V., Identification of highest-affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis, Proc. Natl. Acad. Sci. USA, 89 (1992) 4505-4509.
35. Boutin, J.A., Hennig, P., Lambert, PH., Bertin, S., Petit, L., Mahieu, J.P., Serkiz, B., Volland, J.P.and Fauchére, J.-L., Combinatorial peptide libraries: Robotic synthesis and analysis by nuclear magnetic resonance, mass spectrometry, tandem mass spectrometry, and high-performance capillary electrophoresis techniques, Anal. Biochem., 234 (1996) 126-141.
36. Kleiner, D.E.and Stetler-Stevenson, W.G., Quantitative zymography: Detection of picogram quantities of gelatinases, Anal. Biochem., 218 (1994) 325-329.
37. Davies, B., Brown, P.D., East, N., Crimmin, M.J.and Balkwill, F.R., A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenographs, Cancer Res., 53 (1993) 2087-2091.
38. Owens, R.A., Gesellchen, P.D., Houchins, B.J.and Dimarchi, R.D., The rapid identification of HIV protease inhibitors through the synthesis and screening of defined peptide mixtures, Biochem. Biophys. Res. Commun., 181 (1991) 402-409.
39. Eichler, J.and Houghten, R.A., Identification of substrate-analogue trypsin inhibitors through the screening of synthetic peptide combinatorial libraries, Biochemistry, 41 (1993) 11035-11041.
40. Gallop, M.A., Barrett, R.W., Dower, W.J., Fodor, S.P.W.and Gordon, E.M., Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries, J. Med. Chem., 37 (1994) 1233-1251.
41. Gordon, E.M., Barrett, R., Dower, W.J., Fodor, S.P.W.and Gallop, M.A., Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies and future directions, J. Med. Chem., 37 (1994) 1385-1401.
42. Krchňák, V.and Lebl, M., Synthetic library techniques: Subjective (biased and generic) thoughts and views, Mol. Div., 1 (1995) 193-216.
43. Lebl, M., Krchňák, V, Sepetov, N.F., Seligmann, B., Strop, P., Felder, S.and Lam, K.S., One-bead-one-structure combinatorial libraries, Biopolymers, 37 (1995) 177-195.
44. Smith, M.M., Shi, L.and Navre, M., Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries, J. Biol. Chem., 270 (1995) 6440-6449.
45. Eichler, J., Lucka, A. W.and Houghten, R.A., Cyclic peptide template combinatorial libraries: Synthesis and identification of chymotrypsin inhibitors, Pept. Res., 7 (1994) 300-307.
46. Meldal, M.and Svendsen, I.B., Direct visualization of enzyme inhibitors using a portion mixing inhibitor library containing a quenched fluorogenic peptide substrate. Part 1. Inhibitors for subtilisin Calsberg, J. Chem. Soc. Perkin Trans. I, (1995) 1591-1596.
47. Seligmann, B., Abdul-Latif, F., Al-Obeidi, F., Flegelova, Z., Issakova, O., Kocis, P., Krchňák, V., Lam, K., Lebl, M., Ostrem, J., Safar, P., Sepetov, N., Stierandova, A., Strop, P.and Wild-goose, P., The construction and use of peptide and non-peptidic combinatorial libraries to discover enzyme inhibitors, Eur. J. Med. Chem., 30S (1995) 319s-335s.
48. Yankeelov, J.A., Wacker, W.B.and Schweri, M.M., Radial diffusion assay of tissue collagenase and its application in evaluation of collagenase inhibitors, Biochim. Biophys. Acta, 482 (1977) 159-172.
49. Hare, P., Scott-Burden, T.and Woods, D.R., Characterization of extracellular alkaline proteases and collagenase induction in Vibrio Alginolyticus, J. Gen. Microb., 129 (1983) 1141-1147.
50. Ochieng, J., Fridman, R., Nangia-Makker, P., Kleiner, D., Liotta, L.A., Stetler-Stevenson, W.G.and Raz, A., Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9, Biochemistry, 33 (1994) 14109-14114.
51. Nguyen, Q., Murphy, G., Hughes, C.E., Mort, J.S.and Roughley, P.J., Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein, Biochem. J., 295 (1993) 595-598.
52. Windsor, L.J., Bodden, M.K, Birkedal-Hansen, B., Engler, J.A.and Birkedal-Hansen. H., Mutational analysis of residues in and around the active site of human fibroblast-type collagenase, J. Biol. Chem., 269 (1994) 26201-26207.
53. Vallee, B.L.and Auld, D.S., Zinc coordination, function, and structure of zinc enzymes and other proteins, Biochemistry, 29 (1990) 5647-5659.
54. Stetler-Stevenson, W.G., Talano, J.A., Gallagher, M.E., Krutzsch, H.C.and Liotta, L.A., Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment, Am. J. Med. Sci., 302 (1991) 163-170.
55. Fotouhi, N., Lugo, A.,Visnick, M., Lusch, L., Walsky, R., Coffey, J.W.and Hanglow, A.C., Potent peptide inhibitors of stromelysin based on the prodomain region of matrix inetalloproteinases, J. Biol. Chem., 269 (1994) 30227-30231.
56. Regan, L., Protein design: Novel metal-binding sites, Trends Biochem. Sci., 20 (1995) 280-285.
57. Springman, E.B., Nagase, H., Birkedal-Hansen, H.and Van Wart, H.E., Zinc content and function in human fibroblast collagenase, Biochemistry, 34 (1995) 15713-15720.
58. Otsuka, M., Fujita, M., Aoki, T., Ishii, S., Sugiura, Y., Yamamoto, T.and Inoue, J.I., Novel zinc chelators with dual activity in the inhibition of the KB site-binding proteins HIV-EP1 and NF-κB, J. Med. Chem., 38 (1995) 3264-3270.